CM
BCRX icon

Crestline Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Crestline Management’s Portfolio BCRX Stock Details BCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-149,785
Closed -$1.14M – 724
2024
Q3 		$1.14M Buy
+149,785
New +$1.14M 0.06% 251